Trial Search Results

Clinical Reminders in Test Reports to Improve Guideline Compliance

Although beta-blockers are known to prolong survival for patients with reduced left ventricular ejection fraction, their use in the community and the VA is suboptimal.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

US Department of Veterans Affairs

Stanford Investigator(s):

Intervention(s):

  • Behavioral: Clinical Reminder

Phase:

N/A

Eligibility


Inclusion Criteria:

Those undergoing echocardiography at one of the participating laboratories with an ejection
fraction < 45%.

Exclusion Criteria:

aortic stenosis, mitral stenosis

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting